REPORT: National Advisory Committee To Recommend Suspension Of AstraZeneca Vaccine Use On Canadians Under Age 55

Recommendation by the Canadian National Advisory Committee on Immunization comes amid continued concern around blood clots linked to the AstraZeneca vaccine.

The Canadian National Advisory Committee on Immunization is expected to call for a suspension of all AstraZeneca vaccine injections for Canadians under the age of 55.

The move follows word that Prince Edward Island was halting use of the vaccine for those between the age of 18-29.

Manitoba has since cancelled all vaccination appoints where the AstraZeneca vaccine was to be used.

The AstraZeneca vaccine has also been linked to reports of blood clots among some who received it, findings that were confirmed by scientists in both Norway and Germany who independently came to that conclusion.

Women under the age of 55 appear to be most at risk of the clots forming, according to studies that have been done.

Previously, many European countries had halted the use of the vaccine, though most since restarted.

The Trudeau government has been criticized for Canada’s total reliance on foreign production of vaccines, and many noted how the government made a deal to get AstraZeneca vaccines from the United States, despite the United States not having yet approved it for use on their own people.

Further, many will look at this latest move by the NACI as yet more contradictory advice from the government and various bureaucracies. At least this time however, the move is towards more caution around vaccinations, which is far better than the previous rhetoric of the government which had shown disrespect for people who have legitimate concerns around the vaccination program and the AstraZeneca vaccine in particular.

Spencer Fernando

Photo – YouTube